Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More?

JAMA Cardiol. 2022 Aug 1;7(8):794-795. doi: 10.1001/jamacardio.2022.1572.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / drug therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors